All stock lists
First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX)
US · Delayed Price · Currency is USD
43.62-0.43 (-0.98%)
Insider Score
––Not scored
TRAX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
TRAX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | 207.00 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -207.00 K | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 9.19 M | 18.86 M | 6.63 M | 9.81 M |
| R&D Expense | 25.54 M | 33.95 M | 39.27 M | 41.47 M |
| Operating Expenses | 34.73 M | 52.81 M | 45.90 M | 51.28 M |
| Operating Income | -34.94 M | -52.81 M | -45.90 M | -51.28 M |
| Pretax Income | -33.37 M | -50.48 M | -42.45 M | -47.20 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -33.37 M | -50.48 M | -42.45 M | -47.20 M |
| EPS (Basic) | -0.94 | -1.45 | -1.22 | -1.36 |
| EPS (Diluted) | -0.94 | -1.45 | -1.22 | -1.36 |
| Shares Outstanding | 35.39 M | 34.75 M | 34.75 M | 34.75 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.